Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection.

Evelyn P Parsons1, Angus J Clarke, Don M Bradley

  • 1School of Nursing and Midwifery Studies and Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK. parsonsep@cf.ac.uk

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|May 4, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on Eichinger J, Zimmermann B, Elger B, McLennan S, Filges I, Koné I. 2023. 'It's a nightmare': informed consent in paediatric genome-wide sequencing. A qualitative expert interview study from Germany and Switzerland.

European journal of human genetics : EJHG·2023
Same author

Börjeson-Forssman-Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families.

European journal of human genetics : EJHG·2023
Same author

Response to Beretich and Beretich.

Genetics in medicine : official journal of the American College of Medical Genetics·2023
Same author

The evolving role of medical geneticists in the era of gene therapy: An urgency to prepare.

Genetics in medicine : official journal of the American College of Medical Genetics·2023
Same author

Molecular Pathway-Based Classification of Ectodermal Dysplasias: First Five-Yearly Update.

Genes·2022
Same author

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

Frontiers in neurology·2022

Diagnostic delay in Duchenne Muscular Dystrophy (DMD) is complex. Newborn screening alone may not be sufficient, as early symptoms are often non-specific and missed by primary care. Further investigation into effective screening tools is needed.

Area of Science:

  • Medical Genetics
  • Pediatric Neurology
  • Diagnostic Medicine

Background:

  • Diagnostic delay in Duchenne Muscular Dystrophy (DMD) remains a significant challenge, impacting patient outcomes.
  • Early identification is crucial for timely intervention and management of DMD.
  • Current diagnostic pathways often lead to delayed diagnosis, particularly in primary care settings.

Purpose of the Study:

  • To evaluate the effectiveness of proposed earlier diagnostic strategies for DMD.
  • To analyze the diagnostic pathways and identify factors contributing to delays in clinically diagnosed DMD cases.
  • To assess the utility of newborn screening (NBS) in detecting DMD and reducing diagnostic delay.

Main Methods:

  • Quantitative and semi-qualitative study design.

Related Experiment Videos

  • Inclusion of a newborn screening (NBS) cohort and a clinically diagnosed (LCD) group.
  • Data collection included developmental milestones, Griffiths assessment, clinic letters, family case studies, and semi-structured interviews.

    • Main Results:

    • Previously proposed earlier diagnosis strategies showed limited effectiveness in identifying cases within the NBS cohort.
    • Diagnostic delay is attributed to non-specific initial observations by families, variable symptom presentation, and primary care's limited recognition of early indicators.
    • Early locomotor symptoms were sometimes misattributed, leading to incorrect referrals (e.g., orthopedic instead of pediatric).

    Conclusions:

    • Developing an effective screening tool to reduce DMD diagnostic delay is more complex than anticipated.
    • Service providers must critically evaluate whether newborn screening is the sole feasible solution for addressing diagnostic delays.
    • Further research is needed to identify comprehensive strategies for earlier DMD detection and diagnosis.